| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.0008 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.002 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |